Literature DB >> 15558341

Pseudallescheria boydii cranial osteomyelitis and subdural empyema successfully treated with voriconazole: a case report and literature review.

Z A Kanafani1, Y Comair, S S Kanj.   

Abstract

Described here is a case of Pseudallescheria boydii cranial osteomyelitis and subdural empyema following craniotomy, which was successfully treated with surgical debridement and voriconazole. Other reported cases of Pseudallescheria boydii osteomyelitis are reviewed. The reported case suggests that voriconazole may represent a new therapeutic option for this infection.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15558341     DOI： 10.1007/s10096-004-1233-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  43 in total

1.  In vitro evaluation of voriconazole against some clinically important fungi.

Authors:  M R McGinnis; L Pasarell; D A Sutton; A W Fothergill; C R Cooper; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.

Authors:  A Espinel-Ingroff
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 3.  Osteomyelitis due to Pseudallescheria boydii.

Authors:  L H Hung; L A Norwood
Journal:  South Med J       Date:  1993-02       Impact factor: 0.954

4.  Maduromycosis (Madura foot) in Kentucky.

Authors:  A Warintarawej; W G Winter; N L Goodman
Journal:  South Med J       Date:  1975-12       Impact factor: 0.954

5.  In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.

Authors:  E M Johnson; A Szekely; D W Warnock
Journal:  J Antimicrob Chemother       Date:  1998-12       Impact factor: 5.790

6.  Pseudallescheria boydii arthritis and osteomyelitis in a patient with Cushing's disease.

Authors:  R A Ansari; D A Hindson; D L Stevens; J G Kloss
Journal:  South Med J       Date:  1987-01       Impact factor: 0.954

Review 7.  Current and emerging azole antifungal agents.

Authors:  D J Sheehan; C A Hitchcock; C M Sibley
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

8.  Deep infections from Petriellidium boydii treated with miconazole.

Authors:  L I Lutwick; M W Rytel; J P Yañez; J N Galgiani; D A Stevens
Journal:  JAMA       Date:  1979-01-19       Impact factor: 56.272

9.  An immunocompetent patient with primary Scedosporium apiospermum vertebral osteomyelitis.

Authors:  Nicholas B Levine; Ryu Kurokawa; Carl J Fichtenbaum; John A Howington; Charles Kuntz
Journal:  J Spinal Disord Tech       Date:  2002-10

10.  Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

Authors:  T J Walsh; J W Hiemenz; N L Seibel; J R Perfect; G Horwith; L Lee; J L Silber; M J DiNubile; A Reboli; E Bow; J Lister; E J Anaissie
Journal:  Clin Infect Dis       Date:  1998-06       Impact factor: 9.079
View more
  7 in total

Review 1.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

2.  Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients.

Authors:  Peter Troke; Koldo Aguirrebengoa; Carmen Arteaga; David Ellis; Christopher H Heath; Irja Lutsar; Montserrat Rovira; Quoc Nguyen; Monica Slavin; Sharon C A Chen
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

3.  Pseudallescheria fusoidea, a new cause of osteomyelitis.

Authors:  Mark D Lindsley; Josep Guarro; Raed N Khairy; JoaAnna Williams; Naureen Iqbal; Preeti Pancholi
Journal:  J Clin Microbiol       Date:  2008-04-23       Impact factor: 5.948

4.  Voriconazole in the management of nosocomial invasive fungal infections.

Authors:  Javier Pemán; Miguel Salavert; Emilia Cantón; Isidro Jarque; Eva Romá; Rafael Zaragoza; Angel Viudes; Miguel Gobernado
Journal:  Ther Clin Risk Manag       Date:  2006-06       Impact factor: 2.423

5.  Characterization of Scedosporium apiospermum glucosylceramides and their involvement in fungal development and macrophage functions.

Authors:  Rodrigo Rollin-Pinheiro; Livia Cristina Liporagi-Lopes; Jardel Vieira de Meirelles; Lauro M de Souza; Eliana Barreto-Bergter
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

6.  Scedosporium apiospermum infections and the role of combination antifungal therapy and GM-CSF: A case report and review of the literature.

Authors:  Chloe Goldman; Matthew J Akiyama; Julian Torres; Eddie Louie; Shane A Meehan
Journal:  Med Mycol Case Rep       Date:  2016-04-26

Review 7.  Osteoarticular Infections Caused by Non-Aspergillus Filamentous Fungi in Adult and Pediatric Patients: A Systematic Review.

Authors:  Saad J Taj-Aldeen; Blandine Rammaert; Maria Gamaletsou; Nikolaos V Sipsas; Valerie Zeller; Emmanuel Roilides; Dimitrios P Kontoyiannis; Andy O Miller; Vidmantas Petraitis; Thomas J Walsh; Olivier Lortholary
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.